Literature DB >> 18754669

Intracellular processing of riboflavin in human breast cancer cells.

Lisa M Bareford1, Mitch A Phelps, Amy B Foraker, Peter W Swaan.   

Abstract

A variety of polarized epithelial cells, such as human breast cancer (MCF-7), have mechanistically evolved the ability to adapt to the dynamic cellular environment and maintain homeostasis of an array of micronutrients which display conditional requirements. Active absorption mechanisms, including endocytosis, are able to control cell surface recognition and protein expression which are associated with a substance's intracellular processing and kinetics. Riboflavin (RF), or vitamin B2, has been recognized as an important factor in a multitude of terminal disease states, most notably in breast cancer, where its cellular absorption is significantly enhanced. In order to delineate the regulatory mechanisms and kinetics associated with RF control in human breast cancer tissue, this study aimed to model its absorption profile and identify its intracellular regulatory components. Using both the Michaelis-Menten equation and a modified version of it, incorporating both active internalization and passive diffusion, RF absorption displayed better correlation ( r (2) > 0.998) with the mixed, active and passive, model exhibiting kinetic parameters characteristic of a receptor-mediated uptake mechanism ( J max = 2.58 pmol/5 min, K m = 106 nM) at extracellular RF concentrations under 5 muM and a passive component existing at RF concentrations greater than 5 muM. Following internalization, RF was able to recycle back to the membrane with a half-life of 13.7 min at 37 degrees C, which occurred more rapidly with increasing extracellular RF concentrations ( t 1/2 = 5.4 min at 1 muM) and decreasing temperatures ( t 1/2 = 6.4 min at 4 degrees C). Furthermore, modification to endosomal pH using the lysomotropic agents monensin (25 muM) and primaquine (300 muM) significantly inhibited the exocytosis of RF (61 and 30% of control), whereas biochemical modification of endocytic trafficking with okadaic acid (1 muM) led to a significant increase in RF exocytosis (208%). In conclusion, RF homeostasis in MCF-7 cells is a well regulated process which is dependent upon RF concentration, temperature, and endosomal acidification.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18754669     DOI: 10.1021/mp800046m

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  9 in total

1.  Molecular expression and functional activity of vitamin C specific transport system (SVCT2) in human breast cancer cells.

Authors:  Varun Khurana; Deep Kwatra; Dhananjay Pal; Ashim K Mitra
Journal:  Int J Pharm       Date:  2014-08-04       Impact factor: 5.875

2.  Riboflavin-targeted polymer conjugates for breast tumor delivery.

Authors:  Lisa M Bareford; Brittany R Avaritt; Hamidreza Ghandehari; Anjan Nan; Peter W Swaan
Journal:  Pharm Res       Date:  2013-04-09       Impact factor: 4.200

3.  Riboflavin photoactivation by upconversion nanoparticles for cancer treatment.

Authors:  E V Khaydukov; K E Mironova; V A Semchishen; A N Generalova; A V Nechaev; D A Khochenkov; E V Stepanova; O I Lebedev; A V Zvyagin; S M Deyev; V Ya Panchenko
Journal:  Sci Rep       Date:  2016-10-12       Impact factor: 4.379

4.  Biological activity of PtIV prodrugs triggered by riboflavin-mediated bioorthogonal photocatalysis.

Authors:  Silvia Alonso-de Castro; Alessio Terenzi; Sonja Hager; Bernhard Englinger; Adriana Faraone; Javier Calvo Martínez; Mathea Sophia Galanski; Bernhard K Keppler; Walter Berger; Luca Salassa
Journal:  Sci Rep       Date:  2018-11-21       Impact factor: 4.996

5.  Evaluation of Riboflavin Transporters as Targets for Drug Delivery and Theranostics.

Authors:  Lisa Bartmann; David Schumacher; Saskia von Stillfried; Marieke Sternkopf; Setareh Alampour-Rajabi; Marc A M J van Zandvoort; Fabian Kiessling; Zhuojun Wu
Journal:  Front Pharmacol       Date:  2019-02-06       Impact factor: 5.810

Review 6.  Riboflavin-Targeted Drug Delivery.

Authors:  Milita Darguzyte; Natascha Drude; Twan Lammers; Fabian Kiessling
Journal:  Cancers (Basel)       Date:  2020-01-27       Impact factor: 6.639

Review 7.  Riboflavin: The Health Benefits of a Forgotten Natural Vitamin.

Authors:  Nittiya Suwannasom; Ijad Kao; Axel Pruß; Radostina Georgieva; Hans Bäumler
Journal:  Int J Mol Sci       Date:  2020-01-31       Impact factor: 5.923

8.  Riboflavin ameliorates cisplatin induced toxicities under photoillumination.

Authors:  Iftekhar Hassan; Sandesh Chibber; Aijaz A Khan; Imrana Naseem
Journal:  PLoS One       Date:  2012-05-02       Impact factor: 3.240

9.  Metabolomic alterations in invasive ductal carcinoma of breast: A comprehensive metabolomic study using tissue and serum samples.

Authors:  Tushar H More; Sourav RoyChoudhury; Joel Christie; Khushman Taunk; Anupama Mane; Manas K Santra; Koel Chaudhury; Srikanth Rapole
Journal:  Oncotarget       Date:  2017-12-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.